Neoplasms Clinical Trial
Official title:
Enhanced Self-Efficacy Training For Informal Cancer Caregivers
The goal of this study is to examine the effects of an enhanced caregiver training protocol that not only teaches informal caregivers knowledge and skills for managing patient symptoms, but also provides strategies for managing their own psychological distress. The investigators anticipate this training will increase caregivers' self-efficacy and improve important caregiver outcomes (depression, anxiety, burden, quality of life) and patient outcomes (symptom distress/intensity, depression, anxiety, and quality of life). The study will compare the effects of this protocol to an education control condition that equates for interventionist time and attention.
Symptom management is essential in home caregiving. However, many informal caregivers are
not confident of their ability to assist their their loved ones with their cancer symptoms
at home. A low level of confidence or self-efficacy may negatively affect a caregiver's
psychological well-being which is already vulnerable as a consequence of caregiving. Because
of the reciprocal nature in a caregiver-patient dyad, caregiver decline is likely associated
with patient decline. Improving caregivers' self-efficacy to manage their loved ones'
cancer-related symptoms may mitigate their psychological decline and may positively affect
patients' well-being by alleviating their symptom distress. Additionally, training in
self-management of stress may promote coping among caregivers as many data show that
caregiver stress is overwhelming.
This study will examine the effects of an Enhanced Caregiver Training protocol delivered to
informal caregivers of cancer patients before hospital discharge. The primary aim is to test
the effects of the training on caregivers' self-efficacy in cancer symptom management and
self-efficacy in self-management of stress. The study will also look at the effects of this
training on caregiver outcomes (depression, anxiety, quality of life, caregiver stress) and
patient outcomes (symptom distress and intensity, depression, anxiety, quality of life). The
study will use a treatment and attention-control group. Subjects in the treatment group will
receive an individualized experiential caregiver training in strategies for managing
patient's symptoms and in the use of pleasant imagery and muscle relaxation to manage
stress, whereas subjects in the attention-control group will receive an informational
session about cancer and resources for caregiving. Data will be collected before and after
the training, and at 2 and 4 weeks after hospital discharge. Descriptive statistics and
multivariate analysis including mixed models will be used for data analysis This study could
have important implications for the nursing community on how to effectively prepare informal
cancer caregivers for home caregiving prior to hospital discharge. The long term goal is to
refine and expand the training so that it can be used to teach and support informal
caregivers of patients suffering from other chronic illnesses, and to determine the
cost-effectiveness of this training.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03826043 -
THrombo-Embolic Event in Onco-hematology
|
N/A | |
| Terminated |
NCT03166631 -
A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread
|
Phase 1 | |
| Completed |
NCT01938846 -
BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT06058312 -
Individual Food Preferences for the Mediterranean Diet in Cancer Patients
|
N/A | |
| Completed |
NCT03308942 -
Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants
|
Phase 2 | |
| Recruiting |
NCT06018311 -
Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver Dyads
|
N/A | |
| Withdrawn |
NCT05431439 -
Omics of Cancer: OncoGenomics
|
||
| Completed |
NCT01343043 -
A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma
|
Phase 1 | |
| Completed |
NCT01938638 -
Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer
|
Phase 1 | |
| Recruiting |
NCT05514444 -
Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001)
|
Phase 1 | |
| Recruiting |
NCT02292641 -
Beyond TME Origins
|
N/A | |
| Terminated |
NCT00954512 -
Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04958239 -
A Study to Test Different Doses of BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors)
|
Phase 1 | |
| Recruiting |
NCT04627376 -
Multimodal Program for Cancer Related Cachexia Prevention
|
N/A | |
| Completed |
NCT01222728 -
Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
|
||
| Recruiting |
NCT06004440 -
Real World Registry for Use of the Ion Endoluminal System
|
||
| Active, not recruiting |
NCT05636696 -
COMPANION: A Couple Intervention Targeting Cancer-related Fatigue
|
N/A | |
| Not yet recruiting |
NCT06035549 -
Resilience in East Asian Immigrants for Advance Care Planning Discussions
|
N/A | |
| Recruiting |
NCT06004466 -
Noninvasive Internal Jugular Venous Oximetry
|
||
| Not yet recruiting |
NCT02806557 -
Profiling Neutrophil Counts in Patients on Chemotherapy
|
N/A |